Trending intel short linkNo signup · Email subscription
44.4k following · Pharmaceutical / Weight Loss Drug / China

Phase II Clinical Trial Milestone of Boehringer Pharmaceutical's BGM1812

Follow up on the changes of Phase II clinical trial launch timing, patient enrollment progress and trial result announcement milestones regarding Borui Pharmaceutical's innovative weight loss drug BGM1812.

44.4k following114.3k views
By clicking “Confirm”, you acknowledge that you have read and agree to
/ /
Unlimited Free Public IntelligenceOnly key changes trigger emailsUnsubscribe anytime
Monitor official signalsTrack announcements, filings, company statements, prices, and investor updates.
AI summaryFilter repeated noise and provide concise conclusions with source confidence.
Notify only when usefulNo daily spam. You only get emailed when meaningful progress appears.